7/11/17
Research published in The Lancet reports intriguing results of a retrospective case controlled study done in New Zealand. The Meningococcal B Vaccine used was (MeNZB) due to the Outer-Membrane Vesicle (OMV) vaccine used in Cuba, New Zealand and Norway that suggested a reduction in gonorrhea.